Back to Journals » Journal of Multidisciplinary Healthcare » Volume 18

Instruments for Measuring Healthcare Professionals’ Medication Safety Competence: A Scoping Review

Authors Stephan C , Kloor D, Wurmbach VS, Mahler C

Received 28 November 2024

Accepted for publication 17 February 2025

Published 25 March 2025 Volume 2025:18 Pages 1745—1758

DOI https://doi.org/10.2147/JMDH.S508151

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Scott Fraser



Christoph Stephan,1 Doris Kloor,1 Viktoria Sophie Wurmbach,2 Cornelia Mahler1

1Department of Nursing Science, Institute of Health Sciences, University Hospital Tuebingen, Tuebingen, Baden-Wuerttemberg, Germany; 2Internal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology (Cooperation Unit Clinical Pharmacy), Medical Faculty Heidelberg/Heidelberg University Hospital (Heidelberg University), Heidelberg, Germany

Correspondence: Christoph Stephan, Email [email protected]

Abstract: Elderly patients with chronic diseases often use several drugs (polypharmacy). The more drugs a patient uses, the greater the risk of medication errors. To ensure a safe medication process, healthcare professionals must have a high level of medication safety competence (MSC). Hence, instruments are needed to measure healthcare professionals’ MSC and identify areas where improvement is required. A scoping review was conducted to obtain a comprehensive overview of existing instruments. The scoping review was carried out in accordance with the JBI methodology for scoping reviews and in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). An a priori protocol was registered on Open Science Framework https://osf.io/73dmq. The search, performed in January 2024 in six databases, yielded 3740 results, duplicates were removed and 2499 titles and abstracts were screened. Full text screening of 28 articles resulted in the inclusion and analysis of 15 articles. A total of six instruments were identified, all instruments were designed for nurses or nursing students. However, no instrument to assess, eg physicians’ or pharmacists’ MSC was identified. Five of the six instruments were used in clinical setting and three in educational setting. The Medication Safety Competence Scale (MSCS) and the Medication Safety Scale cover the multidimensionality of MSC. The MSCS’s psychometric properties were considered acceptable. Thus, the MSCS can be used to assess nurses MSC in clinical and educational settings.

Keywords: patient safety, competence assessment, nurses, physicians, pharmacists

Introduction

The older patients are, the more likely they are to have chronic diseases1 and, consequently, to use several drugs (polypharmacy).2,3 Polypharmacy, commonly defined as the use of more than five drugs,4 is associated with an increased risk of adverse health outcomes, such as frailty, hospitalizations and mortality5–7 and has also been linked to drug-related problems, such as inappropriate prescribing and (potential) medication errors (ME).8–10 Such ME can happen at every step of the complex medication process,11 and hence, medication safety is an essential component of patient safety.12 Medication safety is defined as:

Freedom from accidental injury during the course of medication use; activities to avoid, prevent, or correct adverse drug events which may result from the use of medications.13

Medication safety is an essential component of patient safety.13 Therefore, the World Health Organization (WHO) initiated the “Medication without harm” initiative as the third WHO Global Patient Safety Challenge. The goal was to reduce avoidable medication-related harm by 50% worldwide over a period of five years.12 But ensuring a safe medication process remains challenging due to the involvement of different people and different healthcare professionals within this process as well as the complexity of the different settings they are performed in and the medications themselves.14

Thus, all healthcare professionals involved in the medication process, eg physicians, nurses, pharmacists, have to be aware of the risks in the medication process and need to have the necessary competence to prevent ME and improve medication safety. Competence is hereby understood as a combination of knowledge, skills and attitudes15 that refers to the ability to perform a skill and the attribute of the performer, while the term “competency” is used for the “skill” itself.16 To date there is no agreed definition of Medication Safety Competence (MSC). The Safety Competencies Framework17 is a framework of multi-professional patient safety competencies which was originally developed by the Canadian Patient Safety Institute in collaboration with the Royal College of Physicians and Surgeons of Canada and revised in 2020. It comprises six different domains of patient safety competencies: Patient Safety Culture; Teamwork; Communication; Safety, Risk and Quality Improvement; Optimize Human and System Factors; Recognize, Respond to and Disclose Patient Safety Incidents. The concept of this framework was used and adapted for this review. Details are provided in the Methods section.

Medication safety competencies are primarily acquired in the various professional qualification programs, and different concepts have already been developed in order to teach them.18–20 In addition, there are already diverse international education programs to improve the competence of healthcare professionals in relation to (aspects of) MSC in order to increase medication safety in clinical practice.21–23

However, there is still a high prevalence of medication-related harm due to medication errors,24 with negative consequences for patients and high costs for healthcare systems, and in addition, it is not certain that HCPs’ (physicians, pharmacists and nurses) MSC is sufficient to reduce these harms in the future. Thus, assessment instruments to measure MSC are needed to determine whether healthcare professionals have the necessary MSC to ensure a safe medication process within an interprofessional team. It also allows for the identification of competence areas in which HCPs need improvement in order to target their development. This can have implications for professional qualification programs, for example, but also for continuing education activities. Therefore, following this review, a study is planned to evaluate and specifically improve the HCPs MSC.

Previous reviews have considered instruments for measuring patient safety competence25 or specific competencies, such as medication administration skills.26 However, the consideration of patient safety competence is too broad and general to make statements about the specific MSC required and to identify the need for action. Medication administration skills contribute to safety, but relate to the execution of techniques rather than the underlying competence. In addition, previous reviews and instruments often focus on nurses, whereas the interprofessional nature of the medication process requires consideration of all HCPs involved. It is therefore necessary to take a closer look at the specific field of MSC and to identify instruments that will enable all HCPs to be covered.

A search of MEDLINE, the Cochrane Database of Systematic Reviews, JBI Evidence Synthesis and Open Science Framework for existing systematic reviews, scoping reviews or protocols27 on instruments to measure MSC of healthcare professionals did not identify any relevant results. Thus, a scoping review which aimed to identify all relevant assessment instruments that measure the MSC of healthcare professionals was conducted. The review type was chosen as it is a good way of obtaining a comprehensive overview and presenting the current state of research.28 The review therefore offers the possibility of selecting an instrument for assessing the MSC. The assessment allows a structured analysis of the MSC in the different HCPs and the need for action at different levels can be derived.

Review Question

Which instruments are available to assess healthcare professionals’ medication safety competence?

Inclusion Criteria

Participants

The scoping review focused on healthcare professionals, eg nurses, physicians, pharmacists or others without any limitations.

Concept

All studies on instruments assessing medication safety competencies of healthcare professionals were considered. Only studies which focused on quantitative self-assessment instruments, scales, questionnaires or surveys that assess healthcare professionals’ medication safety competence overall or that assess safe medication administrations skills/competencies were considered. Instruments that focused on only one specific skill/competency, such as medication calculation skills, were not included as they do not reflect the multidimensional nature of medication safety.

Context

Studies with participants from any educational, clinical or geographical setting were considered.

Types of Sources

Due to the nature of the scoping review, where critical appraisal of studies is not intended,29,30 all types of studies were included – regardless of whether they were peer reviewed. All studies that describe the development of an instrument assessing the medication safety competencies of healthcare professionals (including psychometric testing) or the administration of an instrument were considered. The scoping review included all quantitative or mixed-methods study designs. Qualitative study designs were not included as the scoping review aimed to identify instruments to assess, not describe, the concept of medication safety competence. In order to capture evidence internationally, sources in all languages were included in the screening process if an English or German abstract was available, but data were only extracted if an English or German translation of the full text was available.

Methods

This scoping review was conducted in accordance with the JBI methodology for scoping reviews,28,31 and in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR).32 The completed PRISMA-ScR Checklist is provided in Appendix 1. The a priori protocol33 was registered34 at Open Science Framework.

Deviations from the Protocol

Due to time constraints, one person (CS) performed the data extraction and another (DK) checked the extracted data to ensure accuracy and completeness.35 Since data extraction is an iterative process, the data extraction form was modified along the way.35 Modifications and rationale are described in the data extraction section. In order to obtain a better overview of the content of the dimensions of the MSC represented in the instruments, the data synthesis was modified. The dimensions considered by the instruments were mapped according to the adapted domains of the Safety Competencies Framework.17

Search Strategy

The development of the search strategy was supported and accompanied by a health sciences librarian. A preliminary search of MEDLINE (PubMed) was carried out to identify keywords and index terms used in the titles and abstracts of relevant sources. The keywords and index terms were used to develop the search strategy for each database. Key studies which were identified in a previous manual search were used to validate the search strategy. Search strategies of the different databases were reviewed and approved by the health sciences librarian. MEDLINE (PubMed), CINAHL (EBSCOhost), Web of Science Core Collection, LIVIVO (excl. MEDLINE), Cochrane Database of Systematic Reviews and Cochrane Central Register of Controlled Trials (Ovid) and CareLit were searched in January 2024. An unsystematic search was conducted in CareLit, a German database of German-language nursing journals, as the systematic search functions in this database are limited. The reference lists of all included articles were screened for additional relevant studies.31 The search strategy is presented in Appendix 2.

Study Selection

Citation details of the identified sources were imported into Rayyan,36 a web app for systematic reviews. Duplicates were automatically removed by Rayyan if the similarity of the citation details was 95% or higher. For lower similarity, duplicates were removed manually. The entire study selection process was conducted by two independent reviewers (CS, DK) and any disagreements were resolved through discussion or with a third reviewer (CM). The inclusion and exclusion criteria were piloted in title/abstract (n=25) and full text (n=4) screening and subsequently updated in the process. Full texts of included articles were retrieved and imported into Rayyan. Full texts which did not meet the eligibility criteria were excluded and reasons for their exclusion are provided in the PRISMA-Flowchart (Figure 1) and in Appendix 3. For the final analysis, all full texts included were managed using the reference management software Zotero (Corporation for Digital Scholarship, Virginia, USA).

Figure 1 PRISMA flow diagram of the study selection process.

Abbreviation: PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.

Notes: *Subsequently included during data extraction (n = 3). Adapted from Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021:n71.37

Data Extraction

The data extraction form developed by the authors (Appendix 4), described in the a priori protocol,33 was piloted (n = 3) and modified in the process: The “Concept” category has been specified to extract subscales and item examples. “Subscales” and “Number of items” have been merged for better overview. The “Analysis and Interpretation” and “Development and Measurement Characteristics” categories have been added as they are relevant to finding a suitable instrument. Data were extracted by one researcher (CS), and all were reviewed by another researcher (DK) to ensure accuracy and completeness.35

Data Analysis and Presentation

In order to answer the research question, the extracted data was summarized in tables and analyzed descriptively. Articles included in the synthesis were categorized based on the instruments included (Table 1). The dimensions of MSC considered in the instruments identified were mapped independently by two researchers (CS, VSW) onto the domains of the Safety Competencies Framework17 and agreement was reached through discussion (Table 2). As medication safety is an essential component of patient safety,12 only minor adjustments in the wording for two of the six original domains were necessary. As a result, the six domains that were used were as follows: Medication Safety Culture; Teamwork; Communication; Safety, Risk and Quality Improvement; Optimize Human and System Factors; Recognize, Respond to and Disclose Medication Incidents. The documented measurement properties were analyzed (Table 3), and the Instruments were analyzed using the PCC framework, including scale rating (Table 4). The primary source of information on instrument content and measurement properties was the original reference of the instrument. As a scoping review was conducted, no critical appraisal of the included articles was performed, nor any risk of bias assessed.32

Table 1 Articles Included to Data Analysis and Synthesis; in Alphabetical Order, by Instrument

Table 2 Instruments’ MSC Dimensions Mapped to the Adapted Form of the Safety Competencies Framework

Table 3 Measurement and Psychometric Properties of the Identified Instruments; in Alphabetical Order

Table 4 Characteristics of the Identified Instruments; in Alphabetical Order

Results

Study Inclusion

The search in the databases yielded 3740 results. 1241 duplicates were removed and 2499 titles and abstracts were screened, of which 25 sources were eligible for full text screening. 13 were excluded as they did not meet the eligibility criteria. Three articles found through citations of included articles during data extraction were subsequently included, resulting in 15 articles included in this review.38–52

The descriptions of the included articles according to the data extraction form are available in Appendix 5. The PRISMA flowchart (Figure 1) shows the study selection process.

Characteristics of Included Sources of Evidence

The included articles were published between 2014 and 2024 and were from twelve different countries, including four from Australia,47–49,52 two each from Iran,40,41 Spain45,46 and Turkey42,51 and one each from China,39 Denmark,44 Finland,43 Korea,38 and Japan.50 All sources were scholarly publications in journals and primary research, reviews were not included. Most of the articles describe the development, translation or adaptation of instruments (n = 11).38–40,42–45,47,49–51 The other articles exclusively focus on the application of instruments (n = 4).41,46,48,52

Review Findings

Six instruments were identified from the 15 articles included (Table 1). All instruments were originally developed and published in English. Two of the instruments were translated into other languages: The Medication Safety Competence Scale (MSCS)38 has been translated into Chinese,39 Turkish42 and Persian.40 The Theory of Planned Behaviour Medication Safety Questionnaire (TPB-MSQ)49 has been translated into Japanese50 and Turkish.51

Two instruments38,43 could be mapped to all six MSC domains of the adapted Safety Competencies Framework (Table 2). The content of one instrument45 could only be assigned to one domain, “Recognize, Respond to and Disclose medication incidents”. At the same time, this domain is the only one matching all instruments. “Teamwork” could be assigned to five of the six instruments, “Optimize Human and Systemic Factors” to the fewest instruments (n = 2).

The items of four of the six instruments were derived from the literature (Table 3). Additionally, interviews were conducted to develop the items for the MSCS and focus group interviews for the TPB-MSQ. For the development of the NORMA and the preparedness for oral medication administration questionnaire, Irujo et al’ questionnaire53 and Fisher & Parolins’ assessment tool54 were adapted, respectively. N.N.’s items reflect the learning objectives of the educational program for which the instrument was designed.

Psychometric properties: Sample sizes ranged from 65 to 607, with no description of calculation methods. NORMA45 was only described up to the pilot test. Cronbach’s alpha of the instruments (n = 3)38,47,49 ranged from 0.844 to 0.96, with only one article43 reporting the Cronbach’s alpha for the individual subscales (0.724–0.864). Face validity was reported in three instruments,38,45,49 and item-level content validity index was reported in one instrument. 38 Pilot testing (n = 4)38,43–45 was conducted with 6–17 participants, with one study44 not reporting a number. Statistical item retention, factorability tests, exploratory factor analysis and confirmatory factor analysis were performed for one instrument.38 One instrument described test–retest reliability.38

All six identified instruments were developed for nurses or nursing students (Table 4). Two instruments were developed for more than one target group. The TPB-MSQ49 was developed for nursing, pharmacy and medicine students and the N.N.44 was developed to assess the competence of social worker, social and healthcare assistants/helpers, non-healthcare background manager and, only one healthcare profession, nurses. Other than nurses, the NORMA was administered on to midwives.46

All instruments were designed in or for the clinical setting, except for the Preparedness for oral medication administration questionnaire47 and the TPB-MSQ.49 Five of the six instruments were used in clinical settings, as the application of the TPB-MSQ in clinical setting was described.50,52 The application of the MSCS in educational settings has also been described.41 Thus, three of the six instruments38,47,49 were applied in educational settings. All instruments use 5- to 7-point Likert scales as rating method (Table 4). The number of items ranges from 17 to 49. For the N.N.44 no final number of items is described. Based on the explanations in the text, it can be assumed that there are at least 22 items. For the TPB-MSQ49 56 items including 5 questions on demographics are described, but the item breakdown shows only 54 items including demographics. Five of the six instruments have subscales.38,43–45,49 The scales differ in the way they are scored. Three instruments43,45,49 allow for a specific analysis and interpretation of subscales.

Discussion

The aim of the scoping review was to identify instruments to measure healthcare professionals’ medication safety competence. Six different instruments were identified in 15 included articles. Two instruments38,49 were translated from English into two50,51 or three39,40,42 other languages.

With the MSCS and the MSS being at least partially assigned to all MSC domains, two instruments could be identified that represent the multidimensionality of the MSC. The fact that the MSC domain “Recognize, Respond to and Disclose Medication Incidents” is covered by all instruments, is in line with the central task of promoting medication safety, as formulated in the WHO’s Global Patient Safety Challenge “Medication Without Harm”: To reduce preventable medication-related harm by addressing harm resulting from errors and unsafe practices.55 “Teamwork” as the second most assigned domain may indicate, that interprofessional collaboration is key to promoting medication safety. The domain “Optimize Human and System Factors” could only be found in two instruments, which may suggest, that it is the area of least awareness or, perhaps that it is not considered possible to change them.

Even though several publications on the development and evaluation of instruments exist,56–59 instrument development, validity and reliability testing was described scarcely and only one article38 described the development and validation process comprehensively. Face and content validity are very important to ensure that the items measure what they are supposed to and are comprehensive.56,60 The Preparedness for oral medication administration questionnaire and the TPB-MSQ were not pilot tested, which may have resulted in poorly worded and unnecessary items.56 The number of participants in the described pilot tests was rather small, although recommendations vary.56,61 Construct validity tests were only performed for the MSCS and the sample size of 607 was evaluated good.38 According to present discussion, the sample sizes of the studies of the other instruments do not appear to be sufficient for further statistical evaluation.62 The measurement properties of the MSCS do not fully meet the criteria for good measurement properties according to the COSMIN guideline.60 The internal consistency of the MSCS,38 the MSS,43 the Preparedness for oral medication administration questionnaire47 and the TPB-MSQ49 can be rated as good.56,60

Descriptions of the development and application of the instruments show that five of the six instruments are applicable in clinical settings38,43–45,49 and three in educational settings.38,47,49 Instruments were mostly developed for the nursing profession. Despite the essential importance of physicians and pharmacists in the medication process and in ensuring medication safety, no instrument could be identified that was developed to assess their competence. Only the TPB-MSQ49 was used to also survey medical and pharmacy students. Interprofessional collaboration is a powerful concept for promoting and ensuring medication safety, including through a better coordination of HCPs’ therapeutic approaches and optimized care processes.63–65 Thus, instruments are needed that can be used in various healthcare professions including physicians and pharmacists. Particularly in the care of polypharmacy patients, all healthcare professions involved need to be competent in medication safety. Only then can MEs be prevented, processes like de-prescribing initiated and safety ensured. At the same time, the result reinforces the important role attributed to nurses in the medication process.66

Limitations

Due to the scoping review methodology, without performance of critical appraisal29,30 of the studies included and differences in the way data were reported in the articles, results and comparisons of results should be treated with caution and no direct conclusions should be drawn from them. A systematic and exhaustive search was conducted, but only articles written in English and German were included, which limits the applicability of the review results to the English and German-speaking world. The validity of the results could have been increased if the entire data extraction process had been carried out by two independent researchers and if authors of the instruments included would have been contacted.

Conclusions

The scoping review identified six instruments38,43–45,47,49 measuring healthcare professionals’ MSC. Two instruments38,43 cover the multidimensionality of MSC by reflecting all the six domains. Since only the MSCS38 has undergone extensive psychometric evaluation and the results can be considered as acceptable, the MSCS can be used to assess MSC. The MSCS has been translated into three other languages,39,40,42 making it available to a wider audience enabling comparison of results in other settings and countries. However, the MSCS was developed and validated in nurses. No instruments to measure MSC were identified for other healthcare professionals.

Implications for Research

In order to further improve medication safety in a targeted manner, instruments are needed to measure the MSC of all healthcare professionals. This can be achieved, either by adapting and evaluating existing instruments, such as the MSCS, or by developing new instruments. Suitable instruments need to be translated into other languages and psychometrically evaluated in order to assess MSC and to compare results with other health professions and settings. The assessment of medication safety competence and identification of areas in which healthcare professionals need improvement in MSC could then lead to interventions to improve medication safety competence and hence medication safety.

Data Sharing Statement

Data supporting the results are shown in the Appendices. Other data are available upon request from the corresponding author.

Acknowledgment

The authors thank Dr Diana Mader, health sciences librarian, for supporting the search process and validating the search strategy.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Funding

No funding was obtained for this study. We acknowledge the support by the Open Access Publishing Fund of the University of Tuebingen.

Disclosure

Dr Viktoria Wurmbach reports personal fees from Landesapothekerkammer Baden-Württemberg, outside the submitted work. Professor Dr Cornelia Mahler reports grants from Bundesministerium für Gesundheit, outside the submitted work. The authors declare no other competing interests in this work.

References

1. Barnett K, Mercer SW, Norbury M, watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet Lond Engl. 2012;380(9836):37–43. doi:10.1016/S0140-6736(12)60240-2

2. Delara M, Murray L, Jafari B, et al. Prevalence and factors associated with polypharmacy: a systematic review and Meta-analysis. BMC Geriatr. 2022;22(1):601. doi:10.1186/s12877-022-03279-x

3. Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med. 2021;12(3):443–452. doi:10.1007/s41999-021-00479-3

4. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. doi:10.1186/s12877-017-0621-2

5. Wastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17(12):1185–1196. doi:10.1080/14740338.2018.1546841

6. Davies LE, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B. Adverse Outcomes of Polypharmacy in Older People: systematic Review of Reviews. J Am Med Dir Assoc. 2020;21(2):181–187. doi:10.1016/j.jamda.2019.10.022

7. Nunes BP, Flores TR, Mielke GI, Thumé E, Facchini LA. Multimorbidity and mortality in older adults: a systematic review and meta-analysis. Arch Gerontol Geriatr. 2016;67:130–138. doi:10.1016/j.archger.2016.07.008

8. Tesfaye WH, Castelino RL, Wimmer BC, Zaidi STR. Inappropriate prescribing in chronic kidney disease: a systematic review of prevalence, associated clinical outcomes and impact of interventions. Int J Clin Pract. 2017;71(7):e12960. doi:10.1111/ijcp.12960

9. Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K. Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol. 2015;71(12):1415–1427. doi:10.1007/s00228-015-1954-4

10. Storms H, Marquet K, Aertgeerts B, Claes N. Prevalence of inappropriate medication use in residential long-term care facilities for the elderly: a systematic review. Eur J Gen Pract. 2017;23(1):69–77. doi:10.1080/13814788.2017.1288211

11. Naseralallah L, Stewart D, Price M, Prevalence PV. contributing factors, and interventions to reduce medication errors in outpatient and ambulatory settings: a systematic review. Int J Clin Pharm. 2023;45(6):1359–1377. doi:10.1007/s11096-023-01626-5

12. World Health Organization. Global patient safety action plan 2021-2030 towards eliminating avoidable harm in health care. World Health Organization. 2021.

13. World Health Organization. Med safety in polypharm.; 2019. Available from: https://www.who.int/publications/i/item/medication-safety-in-polypharmacy-technical-report. Accessed November 27, 2024.

14. Carayon P, Wooldridge A, Hoonakker P, Hundt AS, Kelly MM. SEIPS 3.0: human-centered design of the patient journey for patient safety. Appl Ergon. 2020;84:103033. doi:10.1016/j.apergo.2019.103033

15. Roddrigues M, Fernández-Macías E, Sostero M. A unified conceptual framework of tasks, skills and competences. European Commission. 2021.

16. Khan K, Ramachandran S. Conceptual framework for performance assessment: competency, competence and performance in the context of assessments in healthcare--deciphering the terminology. Med Teach. 2012;34(11):920–928. doi:10.3109/0142159X.2012.722707

17. Canadian Patient Safety Institute. The safety competencies: enhancing patient safety across the health professions.; 2020.

18. Grimes TC, Guinan EM. Interprofessional education focused on medication safety: a systematic review. J Interprof Care. 2023;37(1):131–149. doi:10.1080/13561820.2021.2015301

19. Kasal T, Sabol K. Novel medication safety training module. Am J Health-Syst Pharm AJHP off J Am Soc Health-Syst Pharm. 2022;79(Suppl 4):S123–S127. doi:10.1093/ajhp/zxac176

20. Lee SE, Quinn BL. Incorporating medication administration safety in undergraduate nursing education: a literature review. Nurse Educ Today. 2019;72:77–83. doi:10.1016/j.nedt.2018.11.004

21. Medication safety MSc - postgraduate, interprofessional master’s program of the universities of Bonn, Heidelberg and tuebingen. 2024. Available from: www.amts.uni-bonn.de. Accessed July 8, 2024.

22. ATHINA - Arzneimitteltherapiesicherheit praktisch umsetzen. 2024. Available from: https://www.aknr.de/amts/athina. Accessed July 8, 2024.

23. Certificate of Advanced Studies in Medication Safety University of Bern. 2024. Available from: https://www.unibe.ch/continuing_education_programs/cas_in_medication_safety/index_eng.html. Accessed March 7, 2025.

24. World Health Organization. Global Burden of Preventable Medication-Related Harm in Health Care: A Systematic Review. 1st. World Health Organization; 2024.

25. Mortensen M, Naustdal KI, Uibu E, et al. Instruments for measuring patient safety competencies in nursing: a scoping review. BMJ Open Qual. 2022;11(2):e001751. doi:10.1136/bmjoq-2021-001751

26. Luokkamäki S, Härkänen M, Saano S, Vehviläinen‐Julkunen K. Registered nurses’ medication administration skills: a systematic review. Scand J Caring Sci. 2021;35(1):37–54. doi:10.1111/scs.12835

27. Pollock D, Davies EL, Peters MDJ, et al. Undertaking a scoping review: a practical guide for nursing and midwifery students, clinicians, researchers, and academics. J Adv Nurs. 2021;77(4):2102–2113. doi:10.1111/jan.14743

28. Peters MDJ, Marnie C, Tricco AC, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020;18(10):2119–2126. doi:10.11124/JBIES-20-00167

29. Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and associated methodologies. Health Inf Libr J. 2009;26(2):91–108. doi:10.1111/j.1471-1842.2009.00848.x

30. Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18(1):143. doi:10.1186/s12874-018-0611-x

31. Peters MDJ, Godfrey CM, Munn Z, Tricco AC, Khalil H. Chapter 11: scoping reviews (2020 version). JBI Manual for Evidence Synthesis. 2020. doi:10.46658/JBIMES-20-12

32. Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;(169)(7):467–473. doi:10.7326/M18-0850

33. Stephan C. Instruments for measuring healthcare professionals’ medication safety competence: a scoping review. doi:10.17605/OSF.IO/73DMQ

34. Peters MDJ, Godfrey C, McInerney P, et al. Best practice guidance and reporting items for the development of scoping review protocols. JBI Evid Synth. 2022;20(4):953–968. doi:10.11124/JBIES-21-00242

35. Pollock D, Peters MDJ, Khalil H, et al. Recommendations for the extraction, analysis, and presentation of results in scoping reviews. JBI Evid Synth. 2023;21(3):520–532. doi:10.11124/JBIES-22-00123

36. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. doi:10.1186/s13643-016-0384-4

37. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. Published Online March. 29:2021:n71. doi:10.1136/bmj.n71

38. Park J, Seomun G. Development and validation of the medication safety competence scale for nurses. West J Nurs Res. 2021;43(7):686–697. doi:10.1177/0193945920969929

39. Yang Z, Chen F, Lu Y, Zhang H. Psychometric evaluation of medication safety competence scale for clinical nurses. BMC Nurs. 2021;20(1):165. doi:10.1186/s12912-021-00679-z

40. Mohammadi F, Kouhpayeh SA, Bijani M, Farjam M, Faghihi A, Badiyepeymaiejahromi Z. Translation and psychometric assessment of a Persian version of medication safety competence scale (MSCS) for clinical nurses. Sci Rep. 2023;13(1):2247. doi:10.1038/s41598-023-29399-x

41. Mohebi Z, Bijani M, Dehghan A. Investigating safe nursing care and medication safety competence in nursing students: a multicenter cross-sectional study in Iran. BMC Nurs. 2024;23(1):13. doi:10.1186/s12912-023-01684-0

42. Korkut S, Ulker T. Turkish adaptation of the medication safety competence scale for nurses: validity and reliability study. Int J Caring Sci. 2023;16(2):677–685.

43. Lappalainen M, Härkänen M, Kvist T. The relationship between nurse manager’s transformational leadership style and medication safety. Scand J Caring Sci. 2020;34(2):357–369. doi:10.1111/scs.12737

44. Mygind A, El-Souri M, Rossing C, Thomsen LA. Development and perceived effects of an educational programme on quality and safety in medication handling in residential facilities. Int J Pharm Pract. 2018;26(2):165–173. doi:10.1111/ijpp.12361

45. Salcedo-Diego I, De Andrés-Gimeno B, Ruiz-Antorán B, Layunta R, Serrano-Gallardo P. Diseño y validación de un cuestionario sobre competencia enfermera en la notificación de incidentes por medicamentos. Enferm Clínica. 2017;27(5):278–285. doi:10.1016/j.enfcli.2017.05.006

46. Salcedo‐Diego I, Ruiz‐Antorán B, Payares‐Herrera C, De Andrés‐Gimeno B, Serrano‐Gallardo P. Nurses competence in the reporting of medication‐related incidents: an intervention study. Nurs Open. 2022;9(6):2836–2846. doi:10.1002/nop2.988

47. Aggar C, Dawson S. Evaluation of student nurses’ perception of preparedness for oral medication administration in clinical practice: a collaborative study. Nurse Educ Today. 2014;34(6):899–903. doi:10.1016/j.nedt.2014.01.015

48. Aggar C, Bloomfield JG, Frotjold A, Thomas THT, Koo F. A time management intervention using simulation to improve nursing students’ preparedness for medication administration in the clinical setting: a quasi-experimental study. Collegian. 2018;25(1):105–111. doi:10.1016/j.colegn.2017.04.004

49. Lapkin S, Levett-Jones T, Gilligan C. Using the theory of planned behaviour to examine health professional students’ behavioural intentions in relation to medication safety and collaborative practice. Nurse Educ Today. 2015;35(8):935–940. doi:10.1016/j.nedt.2015.03.018

50. Omura M, Levett‐Jones T, Stone TE, Maguire J, Lapkin S. Measuring the impact of an interprofessional multimedia learning resource on J apanese nurses and nursing students using the T heory of P lanned B ehavior M edication S afety Q uestionnaire. Nurs Health Sci. 2015;17(4):500–506. doi:10.1111/nhs.12224

51. Secginli S, Nahcivan NO, Bahar Z, Fernandez R, Lapkin S. Nursing students’ intention to report medication errors: application of theory of planned behavior. Nurse Educ. 2021;46(6):E169–E172. doi:10.1097/NNE.0000000000001105

52. Fernandez R, tenHam‐Baloyi W, Mathew E, et al. Predicting behavioural intentions towards medication safety among student and new graduate nurses across four countries. J Clin Nurs. 2023;32(5–6):789–798. doi:10.1111/jocn.16330

53. Irujo M, Beitia G, Bes-Rastrollo M, Figueiras A, Hernández-Díaz S, Lasheras B. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Saf. 2007;30(11):1073–1082. doi:10.2165/00002018-200730110-00006

54. Fisher M, Parolin M. The reliability of measuring nursing clinical performance using a competency based assessment tool: a pilot study. Collegian. 2000;7(3):21–27. doi:10.1016/S1322-7696(08)60373-X

55. World Health Organization. Medication Without Harm. March 29, 2017. Available from: https://www.who.int/initiatives/medication-without-harm. Accessed July 8, 2024.

56. Kishore K, Jaswal V, Kulkarni V, De D. Practical guidelines to develop and evaluate a questionnaire. Indian Dermatol Online J. 2021;12(2):266–275. doi:10.4103/idoj.IDOJ_674_20

57. Beatty PC, Collins D, Kaye L, Padilla JL, Willis GB. Advances in Questionnaire Design, Development, Evaluation and Testing. 2020.

58. Ranganathan P, Caduff C. Designing and validating a research questionnaire - part 1. Perspect Clin Res. 2023;14(3):152–155. doi:10.4103/picr.picr_140_23

59. Song Y, Son YJ, Oh D. Methodological Issues in Questionnaire Design. J Korean Acad Nurs. 2015;45(3):323–328. doi:10.4040/jkan.2015.45.3.323

60. Mokkink L, Prinsen C, Patrick D, et al. COSMIN methodology for systematic reviews of patient-reported outcome measures (PROMs) - user manual. 2018;78;(1):6–3.

61. Taherdoost H. Designing a questionnaire for a research paper: a comprehensive guide to design and develop an effective questionnaire. Asian J Manag Sci. 2022;11(1):8–16. doi:10.51983/ajms-2022.11.1.3087

62. Wolf EJ, Harrington KM, Clark SL, Miller MW. Sample size requirements for structural equation models: an evaluation of power, bias, and solution propriety. Educ Psychol Meas. 2013;73(6):913–934. doi:10.1177/0013164413495237

63. Al-Jumaili AA, Doucette WR. Comprehensive literature review of factors influencing medication safety in nursing homes: using a systems model. J Am Med Dir Assoc. 2017;18(6):470–488. doi:10.1016/j.jamda.2016.12.069

64. Chung C, Collins A, Cui N. Development and implementation of an interdisciplinary oncology program in a community hospital. Am J Health Syst Pharm. 2011;68(18):1740–1747. doi:10.2146/ajhp100626

65. Leape LL. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282(3):267. doi:10.1001/jama.282.3.267

66. Choo J, Hutchinson A, Bucknall T. Nurses’ role in medication safety. J Nurs Manag. 2010;18(7):853–861. doi:10.1111/j.1365-2834.2010.01164.x

Creative Commons License © 2025 The Author(s). This work is published by Dove Medical Press Limited, and licensed under a Creative Commons Attribution License. The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/. The license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.